210 related articles for article (PubMed ID: 27782859)
1. Mesenchymal stromal cells derived from cervical cancer produce high amounts of adenosine to suppress cytotoxic T lymphocyte functions.
de Lourdes Mora-García M; García-Rocha R; Morales-Ramírez O; Montesinos JJ; Weiss-Steider B; Hernández-Montes J; Ávila-Ibarra LR; Don-López CA; Velasco-Velázquez MA; Gutiérrez-Serrano V; Monroy-García A
J Transl Med; 2016 Oct; 14(1):302. PubMed ID: 27782859
[TBL] [Abstract][Full Text] [Related]
2. Adenosinergic Immunosuppression by Human Mesenchymal Stromal Cells Requires Co-Operation with T cells.
Kerkelä E; Laitinen A; Räbinä J; Valkonen S; Takatalo M; Larjo A; Veijola J; Lampinen M; Siljander P; Lehenkari P; Alfthan K; Laitinen S
Stem Cells; 2016 Mar; 34(3):781-90. PubMed ID: 26731338
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stromal cells derived from cervical cancer tumors induce TGF-β1 expression and IL-10 expression and secretion in the cervical cancer cells, resulting in protection from cytotoxic T cell activity.
García-Rocha R; Moreno-Lafont M; Mora-García ML; Weiss-Steider B; Montesinos JJ; Piña-Sánchez P; Monroy-García A
Cytokine; 2015 Dec; 76(2):382-390. PubMed ID: 26343835
[TBL] [Abstract][Full Text] [Related]
4. Cervical cancer cells suppress effector functions of cytotoxic T cells through the adenosinergic pathway.
Mora-García ML; Ávila-Ibarra LR; García-Rocha R; Weiss-Steider B; Hernández-Montes J; Don-López CA; Gutiérrez-Serrano V; Titla-Vilchis IJ; Fuentes-Castañeda MC; Monroy-Mora A; Jave-Suárez LF; Chacón-Salinas R; Vallejo-Castillo L; Pérez-Tapia SM; Monroy-García A
Cell Immunol; 2017 Oct; 320():46-55. PubMed ID: 28950987
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal Stromal Cells Derived from Normal Cervix and Cervical Cancer Tumors Increase CD73 Expression in Cervical Cancer Cells Through TGF-β1 Production.
Ávila-Ibarra LR; Mora-García ML; García-Rocha R; Hernández-Montes J; Weiss-Steider B; Montesinos JJ; Lizano Soberon M; García-López P; López CAD; Torres-Pineda DB; Chacón-Salinas R; Vallejo-Castillo L; Pérez-Tapia SM; Monroy-García A
Stem Cells Dev; 2019 Apr; 28(7):477-488. PubMed ID: 30696359
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stromal cells up-regulate CD39 and increase adenosine production to suppress activated T-lymphocytes.
Saldanha-Araujo F; Ferreira FI; Palma PV; Araujo AG; Queiroz RH; Covas DT; Zago MA; Panepucci RA
Stem Cell Res; 2011 Jul; 7(1):66-74. PubMed ID: 21546330
[TBL] [Abstract][Full Text] [Related]
7. In vitro evidence of the presence of mesenchymal stromal cells in cervical cancer and their role in protecting cancer cells from cytotoxic T cell activity.
Montesinos JJ; Mora-García Mde L; Mayani H; Flores-Figueroa E; García-Rocha R; Fajardo-Orduña GR; Castro-Manrreza ME; Weiss-Steider B; Monroy-García A
Stem Cells Dev; 2013 Sep; 22(18):2508-19. PubMed ID: 23656504
[TBL] [Abstract][Full Text] [Related]
8. Adenosine increases PD-L1 expression in mesenchymal stromal cells derived from cervical cancer through its interaction with A
Marín-Aquino LA; Mora-García ML; Moreno-Lafont MC; García-Rocha R; Montesinos-Montesinos JJ; López-Santiago R; Sánchez-Torres LE; Torres-Pineda DB; Weiss-Steider B; Hernández-Montes J; Don-López CA; Monroy-García A
Cell Biochem Funct; 2024 Apr; 42(3):e4010. PubMed ID: 38613217
[TBL] [Abstract][Full Text] [Related]
9. Reply: Adenosine Producing Mesenchymal Stromal Cells.
Kerkelä E
Stem Cells; 2017 Jun; 35(6):1649-1650. PubMed ID: 27862653
[TBL] [Abstract][Full Text] [Related]
10. DSP30 enhances the immunosuppressive properties of mesenchymal stromal cells and protects their suppressive potential from lipopolysaccharide effects: A potential role of adenosine.
Sangiorgi B; De Freitas HT; Schiavinato JL; Leão V; Haddad R; Orellana MD; Faça VM; Ferreira GA; Covas DT; Zago MA; Panepucci RA
Cytotherapy; 2016 Jul; 18(7):846-59. PubMed ID: 27260206
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of T-cell proliferation by murine multipotent mesenchymal stromal cells is mediated by CD39 expression and adenosine generation.
Sattler C; Steinsdoerfer M; Offers M; Fischer E; Schierl R; Heseler K; Däubener W; Seissler J
Cell Transplant; 2011; 20(8):1221-30. PubMed ID: 21176405
[TBL] [Abstract][Full Text] [Related]
12. CD73 Pathway Contributes to the Immunosuppressive Ability of Mesenchymal Stem Cells in Intraocular Autoimmune Responses.
Chen X; Shao H; Zhi Y; Xiao Q; Su C; Dong L; Liu X; Li X; Zhang X
Stem Cells Dev; 2016 Feb; 25(4):337-46. PubMed ID: 26650818
[TBL] [Abstract][Full Text] [Related]
13. Adenosine metabolism of human mesenchymal stromal cells isolated from patients with head and neck squamous cell carcinoma.
Schuler PJ; Westerkamp AM; Kansy BA; Bruderek K; Dissmann PA; Dumitru CA; Lang S; Jackson EK; Brandau S
Immunobiology; 2017 Jan; 222(1):66-74. PubMed ID: 26898925
[TBL] [Abstract][Full Text] [Related]
14. Human graft-derived mesenchymal stromal cells potently suppress alloreactive T-cell responses.
de Mare-Bredemeijer EL; Mancham S; Verstegen MM; de Ruiter PE; van Gent R; O'Neill D; Tilanus HW; Metselaar HJ; de Jonge J; Kwekkeboom J; Hall SR; van der Laan LJ
Stem Cells Dev; 2015 Jun; 24(12):1436-47. PubMed ID: 25744002
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow-derived conventional, but not cloned, mesenchymal stem cells suppress lymphocyte proliferation and prevent graft-versus-host disease in rats.
Kitazawa Y; Li XK; Xie L; Zhu P; Kimura H; Takahara S
Cell Transplant; 2012; 21(2-3):581-90. PubMed ID: 22793067
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of MSC-based enzyme therapy for immunoregulation.
Burr A; Parekkadan B
J Transl Med; 2019 Aug; 17(1):263. PubMed ID: 31409424
[TBL] [Abstract][Full Text] [Related]
17. Human umbilical cord-derived mesenchymal stem cells suppress proliferation of PHA-activated lymphocytes in vitro by inducing CD4(+)CD25(high)CD45RA(+) regulatory T cell production and modulating cytokine secretion.
Yang H; Sun J; Li Y; Duan WM; Bi J; Qu T
Cell Immunol; 2016 Apr; 302():26-31. PubMed ID: 26774852
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity.
Bastid J; Regairaz A; Bonnefoy N; Déjou C; Giustiniani J; Laheurte C; Cochaud S; Laprevotte E; Funck-Brentano E; Hemon P; Gros L; Bec N; Larroque C; Alberici G; Bensussan A; Eliaou JF
Cancer Immunol Res; 2015 Mar; 3(3):254-65. PubMed ID: 25403716
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal Stem/Stromal Cells Derived from Cervical Cancer Promote M2 Macrophage Polarization.
Cortés-Morales VA; Chávez-Sánchez L; Rocha-Zavaleta L; Espíndola-Garibay S; Monroy-García A; Castro-Manrreza ME; Fajardo-Orduña GR; Apresa-García T; Gutiérrez-de la Barrera M; Mayani H; Montesinos JJ
Cells; 2023 Mar; 12(7):. PubMed ID: 37048119
[TBL] [Abstract][Full Text] [Related]
20. CD73 and CD39 ectonucleotidases in T cell differentiation: Beyond immunosuppression.
Bono MR; Fernández D; Flores-Santibáñez F; Rosemblatt M; Sauma D
FEBS Lett; 2015 Nov; 589(22):3454-60. PubMed ID: 26226423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
